Literature DB >> 24275895

Neuropsychological outcomes after psychosocial intervention for depression in Parkinson's disease.

Roseanne D Dobkin, Alexander I Tröster, Jade Tiu Rubino, Lesley A Allen, Michael A Gara, Margery H Mark, Matthew Menza.   

Abstract

The authors describe neuropsychological outcomes in people with Parkinson's disease (PD) after their participation in an NIH-sponsored, randomized, controlled trial of cognitive-behavioral treatment for depression. Improvements in mood were associated with modest gains in verbal memory and executive functioning over the 10-week treatment period and accounted for greater variance in neuropsychological outcomes at the end of treatment than other known correlates of cognitive functioning in PD, such as disease severity, age, and education. Baseline working memory and executive skills were also associated with depression improvement over time.

Entities:  

Mesh:

Year:  2014        PMID: 24275895      PMCID: PMC4144827          DOI: 10.1176/appi.neuropsych.12120381

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  32 in total

1.  The assessment of anxiety states by rating.

Authors:  M HAMILTON
Journal:  Br J Med Psychol       Date:  1959

2.  Do motor and nonmotor symptoms in PD patients predict caregiver strain and depression?

Authors:  Julie H Carter; Barbara J Stewart; Karen S Lyons; Patricia G Archbold
Journal:  Mov Disord       Date:  2008-07-15       Impact factor: 10.338

3.  Cognitive performance in nondemented nonpsychotic Parkinson disease patients with or without a history of depression prior to the onset of motor symptoms.

Authors:  Natasa Klepac; Sanja Hajnsek; Vladimir Trkulja
Journal:  J Geriatr Psychiatry Neurol       Date:  2009-12-08       Impact factor: 2.680

4.  Effects of dopamine agonists on neuropsychiatric symptoms of Parkinson's disease.

Authors:  Irena Rektorová
Journal:  Neurodegener Dis       Date:  2010-03-12       Impact factor: 2.977

Review 5.  A systematic review of prevalence studies of depression in Parkinson's disease.

Authors:  Jennifer S A M Reijnders; Uwe Ehrt; Wim E J Weber; Dag Aarsland; Albert F G Leentjens
Journal:  Mov Disord       Date:  2008-01-30       Impact factor: 10.338

6.  Depression in Parkinson's disease. A positron emission study.

Authors:  H A Ring; C J Bench; M R Trimble; D J Brooks; R S Frackowiak; R J Dolan
Journal:  Br J Psychiatry       Date:  1994-09       Impact factor: 9.319

7.  Depressive symptoms in Parkinson disease correlate with impaired global and specific cognitive performance.

Authors:  Hubert H Fernandez; Reiner H See; Matthew F Gary; Dawn Bowers; Ramon L Rodriguez; Charles Jacobson; Michael S Okun
Journal:  J Geriatr Psychiatry Neurol       Date:  2009-05-08       Impact factor: 2.680

8.  Predictors and course of health-related quality of life in Parkinson's disease.

Authors:  Elin Bjelland Forsaa; Jan Petter Larsen; Tore Wentzel-Larsen; Karen Herlofson; Guido Alves
Journal:  Mov Disord       Date:  2008-07-30       Impact factor: 10.338

9.  Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD Study.

Authors:  Oliver Riedel; Isabella Heuser; Jens Klotsche; Richard Dodel; Hans-Ulrich Wittchen
Journal:  J Geriatr Psychiatry Neurol       Date:  2009-12-30       Impact factor: 2.680

10.  Depression impairs executive functioning in Parkinson disease patients with low educational level.

Authors:  Arthur Kummer; Estefânia Harsányi; Fernando M V Dias; Francisco Cardoso; Paulo Caramelli; Antônio Lúcio Teixeira
Journal:  Cogn Behav Neurol       Date:  2009-09       Impact factor: 1.600

View more
  4 in total

1.  The relationship between telephone-administered cognitive-behavioral therapy for depression and neuropsychological functioning in Parkinson's disease.

Authors:  Roseanne D Dobkin
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2014-04-01       Impact factor: 2.198

Review 2.  Impact of pharmacological and psychological treatment methods of depressive and anxiety disorders on cognitive functioning.

Authors:  Krzysztof Krysta; Marek Krzystanek; Małgorzata Janas-Kozik; Adam Klasik; Irena Krupka-Matuszczyk
Journal:  J Neural Transm (Vienna)       Date:  2014-07-31       Impact factor: 3.575

Review 3.  Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health.

Authors:  Jennifer G Goldman; Beth A Vernaleo; Richard Camicioli; Nabila Dahodwala; Roseanne D Dobkin; Terry Ellis; James E Galvin; Connie Marras; Jerri Edwards; Julie Fields; Robyn Golden; Jason Karlawish; Bonnie Levin; Lisa Shulman; Glenn Smith; Christine Tangney; Cathi A Thomas; Alexander I Tröster; Ergun Y Uc; Noreen Coyan; Crystal Ellman; Mike Ellman; Charlie Hoffman; Susan Hoffman; Don Simmonds
Journal:  NPJ Parkinsons Dis       Date:  2018-06-26

4.  Factors associated with depression in patients with Parkinson's disease A multicenter study in Lima, Peru.

Authors:  Nilton Custodio; Carlos Alva-Diaz; Cristian Morán-Mariños; Koni Mejía-Rojas; David Lira; Rosa Montesinos; Eder Herrera-Pérez; Sheila Castro-Suárez; Yadira Bardales
Journal:  Dement Neuropsychol       Date:  2018 Jul-Sep
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.